NCT00724945

Brief Summary

The purpose of the study is to compare the visual performance of two soft bifocal contact lenses.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
113

participants targeted

Target at P50-P75 for not_applicable

Timeline
Completed

Started Jul 2008

Shorter than P25 for not_applicable

Geographic Reach
1 country

6 active sites

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

July 1, 2008

Completed
24 days until next milestone

First Submitted

Initial submission to the registry

July 25, 2008

Completed
5 days until next milestone

First Posted

Study publicly available on registry

July 30, 2008

Completed
2 days until next milestone

Primary Completion

Last participant's last visit for primary outcome

August 1, 2008

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

August 1, 2008

Completed
1.5 years until next milestone

Results Posted

Study results publicly available

January 27, 2010

Completed
Last Updated

May 21, 2015

Status Verified

May 1, 2015

Enrollment Period

1 month

First QC Date

July 25, 2008

Results QC Date

September 25, 2009

Last Update Submit

May 5, 2015

Conditions

Outcome Measures

Primary Outcomes (3)

  • Distance Visual Acuity

    This outcome measures vision while subjects are looking at objects in the distance and is measures in logMARs.logMAR is the logarithm of the minimum angle of resolution.The ideal is 0.0 and represents 20/20 Snellen acuity.logMAR values \>0.00 indicate vision poorer than ideal and values\<0.0 indicate vision greater than ideal

    after 1 week of wear

  • Near Visual Acuity

    This outcome measures vision while subjects are looking at objects near to them and is measured in logMARs. logMAR is the logarithm of the minimum angle of resolution.The ideal is 0.0 and represents 20/20 Snellen acuity.logMAR values \>0.00 indicate vision poorer than ideal and values\<0.0 indicate vision greater than ideal.

    after 1 week wear

  • Subject Vision

    Subjects responded to "How would you rate the overall quality of vision with these study contact lenses" using the following scale: 1=poor, 2=fair, 3=good, 4=very good, 5=excellent.

    after 1 week wear

Study Arms (2)

senofilcon A / balafilcon A

ACTIVE COMPARATOR

senofilcon A multifocal lenses worn first, balafilcon A multifocal lenses worn second

Device: balafilcon ADevice: senofilcon A

balafilcon A/senofilcon A

ACTIVE COMPARATOR

balafilcon A multifocal lenses worn first, senofilcon A multifocal lenses worn second

Device: balafilcon ADevice: senofilcon A

Interventions

multifocal contact lens

balafilcon A/senofilcon Asenofilcon A / balafilcon A

multifocal contact lens

balafilcon A/senofilcon Asenofilcon A / balafilcon A

Eligibility Criteria

Age35 Years - 70 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • The subject must between 35 and 70 years of age.
  • The subject must have presbyopic symptoms or be already wearing presbyopic contact lens correction.
  • The subject's spherical equivalent distance refraction must be in the range of -1.00 to -6.00 or -9.00 to -10.00 in each eye.
  • Refractive cylinder must be -0.75 D in each eye.
  • The subject must have an ADD power of +0.75D to +2.50D in each eye.
  • The subject must have best corrected visual acuity of 20/20-3 or better in each eye
  • The subject's must have at least 20/30-distance vision OU with the study contact lenses.
  • The subject must agree that they are comfortable with their vision prior to being dispensed the study lenses
  • The subject must be an adapted soft contact lens wearer in both eyes.
  • The subject must appear able and willing to adhere to the instructions set forth in this clinical protocol.
  • The subject must read and sign the STATEMENT OF INFORMED CONSENT and be provided a copy of the form.

You may not qualify if:

  • Ocular or systemic allergies or disease that may interfere with contact lens wear.
  • Systemic disease, autoimmune disease or use of medication, which may interfere with contact lens wear.
  • Clinically significant (grade 3 or 4) corneal edema, corneal vascularization, corneal staining or any other abnormality of the cornea, which may contraindicate contact lens wear
  • Clinically significant (grade 3 or 4) tarsal abnormalities that might interfere with contact lens wear.
  • Any ocular infection.
  • Any corneal distortion resulting from previous hard or rigid gas permeable contact lens wear.
  • Pregnancy or lactation
  • Any infectious disease (e.g., hepatitis, tuberculosis) or an immunosuppressive disease (e.g., HIV).
  • History of diabetes
  • History of binocular vision abnormality or strabismus

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (6)

Dr. James Weber & Associates

Jacksonville, Florida, 32205, United States

Location

Ted Brink & Associates

Jacksonville, Florida, 32256, United States

Location

Unknown Facility

Jacksonville, Florida, 32256, United States

Location

Eye Associates of Winter Park

Winter Park, Florida, 32792, United States

Location

Lee Rigel

East Lansing, Michigan, 48823, United States

Location

Timothy R. Poling, OD

Roanoke, Virginia, 24153, United States

Location

MeSH Terms

Conditions

Presbyopia

Condition Hierarchy (Ancestors)

Refractive ErrorsEye Diseases

Results Point of Contact

Title
Thomas Karkkainen OD
Organization
Vistakon

Publication Agreements

PI is Sponsor Employee
No
Restriction Type
OTHER
Restrictive Agreement
Yes

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
PARTICIPANT
Purpose
TREATMENT
Intervention Model
CROSSOVER
Sponsor Type
INDUSTRY
Responsible Party
SPONSOR

Study Record Dates

First Submitted

July 25, 2008

First Posted

July 30, 2008

Study Start

July 1, 2008

Primary Completion

August 1, 2008

Study Completion

August 1, 2008

Last Updated

May 21, 2015

Results First Posted

January 27, 2010

Record last verified: 2015-05

Locations